Concepedia

Andrew Stone

AS

Statistics

Publications

42

Citations

3.5K

H-Index

28

Active since

1992

Affiliations

Garvan Institute of Medical Research(Current)

St Vincent's Clinic

The Kinghorn Cancer Centre

AstraZeneca (United Kingdom)

Andrew Stone is an author at Garvan Institute of Medical Research specializing in medicine, oncology, and molecular oncology.

Publications per year

1992–2025

42

Publications

42

Stratified Care vs Step Care Strategies for Migraine

Richard B. Lipton, Walter F. Stewart, Andrew Stone et al. · JAMA · 2000 · 366 citations

Pharmacy, Neurology, Pharmacotherapy +11

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

Richard Lafayette, Jens Kristensen, Andrew Stone et al. · The Lancet · 2023 · 289 citations · Full text

Medicine, Nephrology, Pharmacology +12

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†

Martin Jenkins, Andrew Stone, Christopher Jennison · Pharmaceutical Statistics · 2010 · 212 citations

Medicine, Biostatistics, Oncology +15

Hypermutation In Pancreatic Cancer

Jeremy L. Humphris, Ann‐Marie Patch, Kátia Nones et al. · Gastroenterology · 2016 · 208 citations

Medicine, Cancer Biology, Oncology +10

1–5 of 42